Stergiou Angelos M. 4
4 · SELLAS Life Sciences Group, Inc. · Filed Jan 3, 2019
Insider Transaction Report
Form 4
Stergiou Angelos M.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2018-12-31$1.25/sh−23,277$29,189→ 426,858 total
Footnotes (2)
- [F1]The Reporting Person sold such shares to cover personal income tax liability.
- [F2]The price reported is a weighted average price. The shares were sold at prices ranging from $1.23 to $1.31 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.